國家衛生研究院 NHRI:Item 3990099045/10642
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 857818      在线人数 : 834
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10642


    题名: Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-gamma autoantibodies in patients with disseminated nontuberculous mycobacterial infection
    其它题名: Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection
    作者: Wu, UI;Chuang, YC;Sheng, WH;Sun, HY;Jhong, YT;Wang, JY;Chang, SC;Wang, JT;Chen, YC
    贡献者: Division of Infectious Diseases
    摘要: OBJECTIVE: Anti-interferon-gamma (IFN-gamma) autoantibodies (anti-IFN-gamma Abs) have been increasingly recognized as an important cause of disseminated nontuberculous mycobacterial (DNTM) infection, and identification of this immunodeficiency impacts clinical management. However, the protean disease manifestations and inaccessibility to diagnostic tests in clinical settings hamper its early diagnosis. Here, we sought to determine whether QuantiFERON-TB Gold In-tube (QFT-GIT), a commercialized IFN-gamma release assay, could be used to screen for neutralizing anti-IFN-gamma Abs among previously healthy adults with DNTM infection. METHODS: HIV-uninfected patients with DNTM infection were prospectively enrolled for the QFT-GIT assays. We measured their plasma concentration of anti-IFN-gamma Abs and their neutralizing capacity through enzyme-linked immunosorbent assay and flow cytometry. We then analyzed the correlation between QFT-GIT results and the presence of neutralizing anti-IFN-gamma Abs among patients with and without previously recognized immunosuppression, respectively. RESULTS: Irrespective of the autoantibody concentration or disease activity, all patients with neutralizing anti-IFN-gamma Abs (100%, 30/30) had indeterminate QFT-GIT results due to extremely low or undetectable IFN-gamma levels in the mitogen tubes. None of the four DNTM patients who were previously healthy and tested negative of anti-IFN-gamma Abs had an indeterminate QFT-GIT result, and their IFN-gamma levels in the mitogen tube were significantly higher than those of the patients with anti-IFN-gamma Abs (8.28 IU/mL vs. 0.05 IU/mL, P = 0.001). CONCLUSION: An indeterminate QFT-GIT result due to undetectable or extremely low IFN-gamma level in the mitogen tube suggests the presence of neutralizing anti-IFN-gamma Abs in a previously healthy patient with DNTM infection.
    日期: 2018-02
    關聯: Clinical Microbiology and Infection. 2018 Feb;24(2):159-165.
    Link to: http://dx.doi.org/10.1016/j.cmi.2017.06.029
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1198-743x&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000424846600013
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85027467124
    显示于类别:[陳宜君] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB28694201.pdf613KbAdobe PDF379检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈